|
EAPP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.300800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.236340E-03 |
| Normal-vs-Stage2 |
3.011100E-04 |
| Normal-vs-Stage3 |
5.436800E-03 |
| Normal-vs-Stage4 |
2.658400E-02 |
| Stage1-vs-Stage2 |
2.090000E-01 |
| Stage1-vs-Stage3 |
8.185200E-01 |
| Stage1-vs-Stage4 |
8.047800E-01 |
| Stage2-vs-Stage3 |
4.772800E-01 |
| Stage2-vs-Stage4 |
6.678800E-01 |
| Stage3-vs-Stage4 |
9.131200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.822690E-03 |
| Normal-vs-AfricanAmerican |
4.495900E-02 |
| Normal-vs-Asian |
7.898000E-02 |
| Caucasian-vs-AfricanAmerican |
1.481820E-01 |
| Caucasian-vs-Asian |
9.169000E-01 |
| AfricanAmerican-vs-Asian |
5.214000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.222820E-03 |
| Normal-vs-Female |
6.798100E-03 |
| Male-vs-Female |
7.131400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.215970E-02 |
| Normal-vs-Extreme_Weight |
5.262600E-03 |
| Normal-vs-Obese |
1.437930E-02 |
| Normal-vs-Extreme_Obese |
6.566000E-04 |
| Normal_Weight-vs-Extreme_Weight |
9.338200E-01 |
| Normal_Weight-vs-Obese |
5.225400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.556800E-01 |
| Extreme_Weight-vs-Obese |
4.474400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.444010E-01 |
| Obese-vs-Extreme_Obese |
3.905500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.612320E-02 |
| Normal-vs-Age(41-60Yrs) |
2.904100E-02 |
| Normal-vs-Age(61-80Yrs) |
4.34990000000024E-05 |
| Normal-vs-Age(81-100Yrs) |
1.377510E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.430200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.834800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.537800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.274060E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.808200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.910600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.674100E-02 |
| Normal-VS-Type2 PRCC |
1.04759999997039E-06 |
| Normal-VS-KIRP CIMP |
1.359640E-03 |
| Normal-VS-Unclassified PRCC |
6.537400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.439400E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.007770E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.991370E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.638200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.160400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.231600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.54816999999863E-05 |
| Normal-vs-N1 |
1.048840E-01 |
| Normal-vs-N2 |
2.31492602864591E-12 |
| N0-vs-N1 |
2.232000E-02 |
| N0-vs-N2 |
4.2690999957351E-08 |
| N1-vs-N2 |
6.08419999936771E-08 |
|
|
